Feature Article

The relative risk for healthcare-associated infections has decreased in the last 15 years due to improvements in awareness of risk associated with devices, infection control, and evidence-based practice regarding use of devices.

Latest News

B-Cell Depletion Therapy With Rituximab Effective for Cutaneous Lupus Erythematosus


Although patients with CCLE responded well, the numbers were small and additional research with respect to this finding is warranted.

Baricitinib Gets Fast Track Status for Systemic Lupus Erythematosus


Data from a Phase 2 trial of baricitinib for the treatment of SLE supporting the Fast Track designation were published in The Lancet and presented at the European Congress of Rheumatology earlier this year.

Assessment of Pediatric Cutaneous Lupus With CLASI Easier, More Reliable Than PGA


A majority of the physician participants reported that CLASI was an easier tool to use compared with PGA.

Belimumab Aids Anti-dsDNA-Positive Hypocomplementemic Lupus

Weekly belimumab is associated with greater benefit than placebo for patients with hypocomplementemic/anti-double stranded (ds)DNA-positive systemic lupus erythematosus.

Thalidomide Not Associated With Risk for Thromboembolic Events in CLE

The risk for all TEs was significantly higher in those with a history of prior arterial thrombosis and hypercholesterolemia.

Comorbidities Associated With Pyoderma Gangrenosum Vary With Age


The findings of this study may allow for the development of algorithms that prioritize patient evaluations based on age.

Recording Site and Severity of Oral Pemphigus Vulgaris With New Tool


The ODSS tool is among the quickest to use among patients with oral pemphigus vulgaris.

Stem Cell Transplant May Hold Benefits for Systemic Sclerosis

In the absence of an effective pharmacotherapy for systemic sclerosis, researchers suggest stem cell transplant may have potential in the management of cutaneous and internal organ manifestations.

Skin Biopsy May Be Required to Improve Diagnosis of Amyopathic Dermatomyositis


The consideration of additional variables, such as skin biopsy, should be used to involve more patients and prevent the inclusion of any cutaneous diseases that mimic ADM.

Lasting Benefits for Scleroderma With Stem-Cell Transplantation

Myeloablative autologous hematopoietic stem-cell transplantation linked to improved survival in severe scleroderma.

Sign up for Newsletters